doi:10.4103/0974-7753.114714 [8] Polegato BF, Pereira AG, Azevedo PS, et al
Comment: Commenters supported our proposal to continue our low volume APC policy
You should use this injection only under medical supervision and exactly as prescribed
Timing considerations Morning and evening applications are common for twice-daily protocols
In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
myhealth.alberta.ca